Artia Global Partners’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-40,000
Closed -$3.64M 43
2023
Q1
$3.64M Buy
+40,000
New +$3.64M 1.34% 15